Jamey Millar is Executive Vice President, US Operations of Novo Nordisk Inc. Jamey has responsibility for the operations in the US, Novo Nordisk’s largest sales region.

A senior healthcare executive with more than 30 years of experience across the pharmaceutical, payer, and distribution sectors, Jamey brings deep expertise in US commercial strategy, market access, and enterprise leadership within large, complex healthcare organizations.

Prior to joining Novo Nordisk, Jamey served as Chief Executive Officer of Optum Specialty Holdings at UnitedHealth Group, where he was responsible for building and scaling specialty distribution and biosimilars businesses. He previously held senior leadership roles at OptumRx, where he led Industry Relations (including responsibility for all manufacturer contracting), and at GlaxoSmithKline, including roles leading the U.S. oncology business and managed markets and government affairs. Earlier in his career, Jamey worked for Procter and Gamble Pharmaceuticals and held various roles including General Manager for the United Kingdom, Netherlands, and Ireland.

Jamey’s experience spans commercial operations, market access, pricing, government affairs, and business development. His background across pharmaceutical and healthcare services organizations provides an integrated perspective on the U.S. healthcare ecosystem in support of long-term growth and patient access.